The AMH median levels were 1.4 ± 1.8, 2.5 ± 3.2 and 1.7 ± 1 ng/ml for the hematological malignancy group, solid tumor group and benign disease group, respectively (ng/ml ± interquartile range). Here, AMH is linked to hematologic disorder.